home > News and Publications > Publications

  • Sign Up to Receive ISMS Legislative Alerts – Via Text!

    If you want to receive “Call to Action” text alerts from ISMS on key legislative issues, text IL DOCS to 50457. Once you opt in, you’ll receive occasional text alerts that include a link with details about the issue and how to contact your individual lawmaker(s).

    Sign up today by texting IL DOCS to 50457

  • Round 3: FDA Advisory Panel to Review Johnson & Johnson’s COVID-19 Vaccine Friday

    A third COVID-19 vaccine is likely to gain emergency use approval by the U.S. Food and Drug Administration (FDA) very soon.

    Clinical trials have indicated that a single dose of the Johnson & Johnson vaccine had an efficacy rate of up to 72%. Today the Vaccines and Related Biological Products Advisory Committee, made up of nongovernmental scientists and public health experts from across the United States, will review and vote on whether to recommend Johnson & Johnson's COVID-19 vaccine to the FDA for emergency use. FDA staff endorsed emergency approval of the vaccine on Wednesday. 

    In late 2020, this same advisory panel recommended that the FDA approve the Pfizer-BioNTech and the Moderna COVID-19 vaccines for emergency use, which the FDA approved one day later in both cases. 

    Stay tuned for the panel’s vote, coming today.

    If you have questions, please contact the ISMS Health Policy Research and Advocacy team by email

  • Apply Now for an Opioid Use Disorder Treatment Fellowship Program

    The deadline to apply is March 5

    A nine-month fellowship program designed to train Illinois primary care health professionals in the assessment and treatment of opioid use disorders (OUD) will be starting soon! 

    The training will provide clinical guidance, technical support around clinical workflows, protocols to ensure compliance with clinical standards, and training in evidence-based practice.

    Up to $2,000 in training reimbursement is available upon completion of the fellowship.

    Here’s how the fellowship training is structured:

    1.   Participants must attend the interactive online Weekend Immersion Course, taking place on Friday, May 1 and Saturday, May 2.

    2.   After completing the Weekend Immersion Course, participants must attend at least twenty weekly webinars on Tuesdays, from noon to 1 p.m. (starting June 29, 2021, and ending Feb. 15, 2022) 

    3.   Prior to taking the Weekend Immersion Course, participants must have taken the MAT waiver training. Physicians may take the 8 hour online MAT waiver training at no cost here.

    Those interested in the fellowship program must apply by March 5, 2021.

    If you have questions, please contact the ISMS Health Policy Research and Advocacy team by email.  

  • Are Your Patients with COVID-19 Eligible for Monoclonal Antibody Treatment?

    Patients who test positive for COVID-19 may qualify to receive monoclonal antibody treatment (casirivimab and imdevimab).

    The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for these medications last November for mild or moderate cases of COVID-19 in adults and children who are at high risk with at least one health condition

    In a clinical trial of patients with COVID-19, monoclonal antibody treatment reduced hospitalization or emergency room visits in high risk patients. The safety and effectiveness of this treatment for COVID-19 continues to be evaluated.

    The U.S. Department of Health and Human Services offers a resource to help patients find locations for monoclonal antibody treatment: Therapeutics Distribution Locations.

    For more information, download the Illinois Department of Public Health’s InfoSheet

    If you have questions, please contact the ISMS Health Policy Research and Advocacy team by email

  • Immunization Education Available for Doctors at No Cost

    CME offered 

    The Illinois Chapter of the American Academy of Pediatrics (ICAAP) is working in collaboration with the Chicago Department of Public Health and the Illinois Department of Public Health to offer free immunization education throughout the year.

    Here are a few of the upcoming ICAAP webinars, also offering CME:

    For more information, access ICAAP’s Immunization Resources web page that provides information specifically geared for healthcare professionals.

    If you have questions, please contact the ISMS Health Policy Research and Advocacy team by email

  • Tax Season is Here! A Large Portion of Your ISMS Dues Is Tax-Deductible

    The portion of your ISMS dues for the 2020 membership year supporting non-tax-deductible activities is 10%.

    Therefore, for federal income tax purposes, your dues for 2020 are 90% percent tax-deductible.

    For applicability to your individual circumstances, check with your tax consultant or advisor.

  • ISMS Welcomes New Members

    Thank you for joining the Illinois State Medical Society (ISMS)!

    ISMS is the community for all physicians to be heard in Illinois. Your membership in ISMS provides you with some incredible opportunities and access to a team of individuals working tirelessly to provide you the resources and support you need throughout your medical career.

    ISMS is dedicated to addressing your needs and to making positive changes in the healthcare environment in our state. Welcome to ISMS!

    New members

View Full Site View Mobile Site